This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1998 Apr;114(4):842-5.

doi: 10.1016/s0016-5085(98)70599-2.

Steatohepatitis: a tale of two "hits"?

C P Day, O F James

PMID: 9547102
DOI: 10.1016/s0016-5085(98)70599-2

Editorial

Steatohepatitis: a tale of two "hits"?

C P Day et al. Gastroenterology. 1998 Apr.

. 1998 Apr;114(4):842-5.

doi: 10.1016/s0016-5085(98)70599-2.

Authors

C P Day, O F James

PMID: 9547102
DOI: 10.1016/s0016-5085(98)70599-2

No abstract available

PubMed Disclaimer

Similar articles

Nonalcoholic steatohepatitis.
Redlich CA, Cullen MR. Redlich CA, et al. Ann Intern Med. 1997 Sep 1;127(5):410; author reply 411. doi: 10.7326/0003-4819-127-5-199709010-00014. Ann Intern Med. 1997. PMID: 9273836 No abstract available.
Tamoxifen-induced steatohepatitis.
Van Hoof M, Rahier J, Horsmans Y. Van Hoof M, et al. Ann Intern Med. 1996 May 1;124(9):855-6. doi: 10.7326/0003-4819-124-9-199605010-00015. Ann Intern Med. 1996. PMID: 8610959 No abstract available.
The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Nonalcoholic steatohepatitis.
Maher J. Maher J. Hepatology. 2001 Jan;33(1):311-2. doi: 10.1053/jhep.2001.0330311. Hepatology. 2001. PMID: 11124851 No abstract available.
[Role of mitochondria in drug-induced hepatotoxicity].
Berson A, Fromenty B, Lettéron P, Pessayre D. Berson A, et al. Gastroenterol Clin Biol. 1998 Jan;22(1):59-72. Gastroenterol Clin Biol. 1998. PMID: 9762168 Review. French. No abstract available.
Nonalcoholic steatohepatitis (NASH): further expansion of this clinical entity?
Brunt EM. Brunt EM. Liver. 1999 Aug;19(4):263-4. doi: 10.1111/j.1478-3231.1999.tb00047.x. Liver. 1999. PMID: 10459622 Review. No abstract available.

See all similar articles

Cited by

A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.
Xu Y, Zalzala M, Xu J, Li Y, Yin L, Zhang Y. Xu Y, et al. Nat Commun. 2015 Jun 23;6:7466. doi: 10.1038/ncomms8466. Nat Commun. 2015. PMID: 26100857 Free PMC article.
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review.
Delli Bovi AP, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P. Delli Bovi AP, et al. Front Med (Lausanne). 2021 Feb 26;8:595371. doi: 10.3389/fmed.2021.595371. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33718398 Free PMC article. Review.
Pediatric metabolic syndrome: from prevention to treatment.
Kelishadi R, Poursafa P, de Ferranti SD, Schwandt P, Adeli K, Onat A, Gidding SS. Kelishadi R, et al. Cholesterol. 2012;2012:374168. doi: 10.1155/2012/374168. Epub 2012 Nov 11. Cholesterol. 2012. PMID: 23198141 Free PMC article. No abstract available.
B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease.
Miyake T, Abe M, Tokumoto Y, Hirooka M, Furukawa S, Kumagi T, Hamada M, Kawasaki K, Tada F, Ueda T, Hiasa Y, Matsuura B, Onji M. Miyake T, et al. Hepatol Int. 2013 Jun;7(2):539-47. doi: 10.1007/s12072-012-9345-8. Epub 2012 Feb 9. Hepatol Int. 2013. PMID: 26201785
Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Beaton MD. Beaton MD. Can J Gastroenterol. 2012 Jun;26(6):353-7. doi: 10.1155/2012/725468. Can J Gastroenterol. 2012. PMID: 22720278 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information